Ubs Group Ag Johnson & Johnson Put Options Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

Put Options

30 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $28.6 Million - $31.3 Million	-198,415 Reduced 27.36%	526,729 $77 Million
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $38.3 Million - $40.2 Million	-246,837 Reduced 25.4%	725,144 $115 Million
Q4 2023 Feb 09, 2024	BUY	$145.6 - $158.88 $64.6 Million - $70.5 Million	443,581 Added 83.95%	971,981 $152 Million
Q3 2023 Nov 09, 2023	BUY	$155.75 - $174.48 $12.2 Million - $13.6 Million	78,200 Added 17.37%	528,400 $82.3 Million
Q2 2023 Aug 11, 2023	BUY	$154.35 - $166.11 $3.69 Million - $3.97 Million	23,900 Added 5.61%	450,200 $74.5 Million
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $53.4 Million - $63.7 Million	-353,200 Reduced 45.31%	426,300 $66.1 Million
Q4 2022 Feb 08, 2023	BUY	$160.2 - $179.79 $18 Million - $20.2 Million	112,300 Added 16.83%	779,500 $138 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $37.6 Million - $41.8 Million	233,100 Added 53.7%	667,200 $109 Million
Q2 2022 Aug 10, 2022	SELL	$168.19 - $186.01 $20 Million - $22.2 Million	-119,100 Reduced 21.53%	434,100 $77.1 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $5.08 Million - $5.76 Million	-32,100 Reduced 5.48%	553,200 $98 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $16 Million - $17.8 Million	102,876 Added 21.32%	585,300 $100 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $16.1 Million - $17.9 Million	-99,500 Reduced 17.1%	482,424 $77.9 Million
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $2.95 Million - $3.16 Million	18,500 Added 3.28%	581,924 $95.9 Million
Q1 2021 May 12, 2021	BUY	$153.07 - $170.48 $80,208 - $89,331	524 Added 0.09%	563,424 $92.6 Million
Q4 2020 Feb 11, 2021	BUY	$137.11 - $157.38 $11.9 Million - $13.6 Million	86,500 Added 18.16%	562,900 $88.6 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $3.03 Million - $3.32 Million	21,600 Added 4.75%	476,400 $70.9 Million
Q2 2020 Jul 31, 2020	SELL	$128.81 - $155.51 $10.4 Million - $12.6 Million	-80,900 Reduced 15.1%	454,800 $64 Million
Q1 2020 May 01, 2020	BUY	$111.14 - $153.99 $28.9 Million - $40 Million	259,600 Added 94.02%	535,700 $70.2 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $5.58 Million - $6.41 Million	43,800 Added 18.85%	276,100 $40.3 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $8.81 Million - $9.86 Million	69,400 Added 42.6%	232,300 $30.1 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $49.1 Million - $54 Million	-374,500 Reduced 69.69%	162,900 $22.7 Million
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $26.5 Million - $29.4 Million	-210,500 Reduced 28.15%	537,400 $75.1 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $45.2 Million - $54.4 Million	368,000 Added 96.87%	747,900 $96.5 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $35.4 Million - $41.6 Million	291,400 Added 329.27%	379,900 $52.5 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $13.2 Million - $14.5 Million	-110,200 Reduced 55.46%	88,500 $10.7 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $4 Million - $4.74 Million	32,000 Added 19.2%	198,700 $25.5 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $1.39 Million - $1.52 Million	-10,600 Reduced 5.98%	166,700 $23.3 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $8.09 Million - $8.46 Million	62,500 Added 54.44%	177,300 $23.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	82,400 Added 254.32%	114,800 $15.2 Million
Q1 2017 Nov 14, 2017	BUY	N/A	32,400	32,400 $4.04 Million

Others Institutions Holding JNJ

# of Institutions

4,160

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $433B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account